Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Renal pelvic cancer with spleen invasion arising in horseshoe kidney; a case report.

Ito A, Kato Y, Shiomi E, Ishii S, Suzuki M, Omori S, Abe T, Tanji S, Sugai T, Obara W.

Urol Case Rep. 2017 Dec 5;16:123-125. doi: 10.1016/j.eucr.2017.11.031. eCollection 2018 Jan. No abstract available.

2.

Multi-institutional retrospective analysis of learning curves on dosimetry and operation time before and after introduction of intraoperatively built custom-linked seeds in prostate brachytherapy.

Ishiyama H, Satoh T, Yorozu A, Saito S, Kataoka M, Hashine K, Nakamura R, Tanji S, Masui K, Okihara K, Ohashi T, Momma T, Aoki M, Miki K, Kato M, Morita M, Katayama N, Nasu Y, Kawanaka T, Fukumori T, Ito F, Shiroki R, Baba Y, Inadome A, Yoshioka Y, Takayama H, Hayakawa K.

J Radiat Res. 2016 Jan;57(1):68-74. doi: 10.1093/jrr/rrv065. Epub 2015 Oct 22.

3.

Three-dimensional summation of rectal doses in brachytherapy combined with external beam radiotherapy for prostate cancer.

Kikuchi K, Nakamura R, Tanji S, Yamaguchi S, Kakuhara H, Yabuuchi T, Inatsu W, Oikawa H, Ariga H.

Radiother Oncol. 2013 May;107(2):159-64. doi: 10.1016/j.radonc.2013.03.003. Epub 2013 Mar 27.

PMID:
23541641
4.

Neoadjuvant gemcitabine plus carboplatin for locally advanced bladder cancer.

Iwasaki K, Obara W, Kato Y, Takata R, Tanji S, Fujioka T.

Jpn J Clin Oncol. 2013 Feb;43(2):193-9. doi: 10.1093/jjco/hys213. Epub 2012 Dec 28.

PMID:
23275643
5.

Narrow safety range of intraoperative rectal irradiation exposure volume for avoiding bleeding after seed implant brachytherapy.

Nakamura R, Kikuchi K, Tanji S, Yabuuchi T, Uwano I, Yamaguchi S, Ariga H, Fujioka T.

Radiat Oncol. 2012 Jan 31;7:15. doi: 10.1186/1748-717X-7-15.

6.

Matched-pair analysis and dosimetric variations of two types of software for interstitial permanent brachytherapy for prostate cancer.

Ishiyama H, Nakamura R, Satoh T, Tanji S, Teh BS, Uemae M, Baba S, Hayakawa K.

Med Dosim. 2012 Spring;37(1):84-6. doi: 10.1016/j.meddos.2011.01.004. Epub 2011 Sep 19.

PMID:
21937217
7.

[Integrating teaching nursing work and citizenship].

Tanji S, da Silva CM, Albuquerque VS, Viana Lde O, dos Santos NM.

Rev Gaucha Enferm. 2010 Sep;31(3):483-90. Portuguese.

PMID:
21574333
8.

Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase.

Pandey PR, Okuda H, Watabe M, Pai SK, Liu W, Kobayashi A, Xing F, Fukuda K, Hirota S, Sugai T, Wakabayashi G, Koeda K, Kashiwaba M, Suzuki K, Chiba T, Endo M, Fujioka T, Tanji S, Mo YY, Cao D, Wilber AC, Watabe K.

Breast Cancer Res Treat. 2011 Nov;130(2):387-98. doi: 10.1007/s10549-010-1300-6. Epub 2010 Dec 29.

9.

Effects of ellipsoid prostate deformation on dose delivery during permanent interstitial brachytherapy.

Nakamura R, Ishiyama H, Tanji S, Satoh T, Oikawa H, Inatsu W, Ehara S, Hayakawa K.

Brachytherapy. 2011 May-Jun;10(3):208-13. doi: 10.1016/j.brachy.2010.01.002. Epub 2010 Aug 4.

PMID:
20685175
10.

Differences between intraoperative ultrasound-based dosimetry and postoperative computed tomography-based dosimetry for permanent interstitial prostate brachytherapy.

Ishiyama H, Nakamura R, Satoh T, Tanji S, Uemae M, Baba S, Hayakawa K.

Brachytherapy. 2010 Jul-Sep;9(3):219-23. doi: 10.1016/j.brachy.2009.09.007. Epub 2010 Feb 1.

PMID:
20122874
11.

Inter-software variability in post-implanted CT analysis for interstitial permanent brachytherapy for prostate cancer: differences in automatically detected seed location.

Ishiyama H, Nakamura R, Satoh T, Tanji S, Uemae M, Baba S, Hayakawa K.

Radiother Oncol. 2008 Nov;89(2):214-6. doi: 10.1016/j.radonc.2008.07.001. Epub 2008 Aug 11.

PMID:
18701179
12.
13.

Eight year experience with Studer ileal neobladder.

Obara W, Isurugi K, Kudo D, Takata R, Kato K, Kanehira M, Iwasaki K, Tanji S, Konda R, Fujioka T.

Jpn J Clin Oncol. 2006 Jul;36(7):418-24. Epub 2006 Jun 27.

PMID:
16803843
14.

Synthesis study of 3'-alpha-fluoro-2',3'-dideoxyguanosine.

Torii T, Onishi T, Tanji S, Izawa K.

Nucleosides Nucleotides Nucleic Acids. 2005;24(5-7):1051-4.

PMID:
16248090
15.

Perinephric angiomyolipoma: a unique development pattern surrounding the kidney.

Obara W, Sato K, Owari Y, Nozawa T, Isurugi K, Ohmori S, Matsushita Y, Tanji S, Konda R, Fujioka T.

Int J Urol. 2005 Mar;12(3):305-7.

16.

[Refractory germ cell cancer of testis treated by salvage high-dose chemotherapy: report of three cases].

Tanji S, Obara W, Sugimura J, Ohmori S, Matsushita Y, Tokunaga H, Konda R, Fujioka T, Murai K, Ishida Y.

Hinyokika Kiyo. 2004 Feb;50(2):77-80. Japanese.

17.
18.

Asymmetric synthesis with a chiral catalyst generated from asymmetric autocatalysis.

Sato I, Urabe H, Ishii S, Tanji S, Soai K.

Org Lett. 2001 Nov 29;3(24):3851-4.

PMID:
11720552
19.

[A case of congenital hydronephrosis suffering from rupture of the renal pelvis due to trauma].

Obara W, Ohuchi A, Sugimura J, Tokunaga H, Tanji S, Fujioka T.

Hinyokika Kiyo. 2001 Jun;47(6):425-7. Japanese.

20.

Asymmetric autocatalysis of a pyrimidyl alkanol induced by chiral monosubstituted [2.2]paracyclophanes.

Tanji S, Ohno A, Sato I, Soai K.

Org Lett. 2001 Jan 25;3(2):287-9.

PMID:
11430056
21.

[A case of ureterovesical malacoplakia that manifested hydronephrosis].

Kato T, Suzuki Y, Sugimura J, Isurugi K, Obara W, Tanji S, Fujioka T.

Hinyokika Kiyo. 2001 Mar;47(3):195-7. Japanese.

22.

Combined total replacement of the suprarenal inferior vena cava with a polytetrafluoroethylene tube graft and hepatic vein reconstruction for renal cell carcinoma.

Fujioka T, Sugimura J, Hasegawa M, Tanji S, Sasaki R, Komoda K.

J Urol. 2000 Jun;163(6):1861-2. No abstract available.

PMID:
10799202
23.

Telomerase activity in human renal cell carcinoma.

Fujioka T, Hasegawa M, Suzuki Y, Suzuki T, Sugimura J, Tanji S, Koike H.

Int J Urol. 2000 Jan;7(1):16-21.

24.

Long-term follow-up of the Indiana pouch: efficacy of the pouch construction using the absorbable gastrointestinal staples.

Fujioka T, Ujiie T, Suzuki K, Okamoto T, Hasegawa M, Tanji S, Koike H.

Int Surg. 1999 Jan-Mar;84(1):49-56.

PMID:
10421019
25.

[Metastatic renal tumor originating from esophageal carcinoma: a case report].

Matsushita Y, Katoh T, Isurugi K, Obara W, Suzuki T, Tamura T, Tanji S, Fujioka T.

Hinyokika Kiyo. 1998 Aug;44(8):591-4. Review. Japanese.

26.

Inhibition of tumor growth and angiogenesis by vitamin D3 agents in murine renal cell carcinoma.

Fujioka T, Hasegawa M, Ishikura K, Matsushita Y, Sato M, Tanji S.

J Urol. 1998 Jul;160(1):247-51.

PMID:
9628658
27.

[Primary squamous cell carcinoma of the prostate: a case report].

Okamoto T, Ogiu K, Sato M, Kaneko T, Suzuki Y, Tanji S, Fujioka T.

Hinyokika Kiyo. 1996 Jan;42(1):67-70. Review. Japanese.

28.

Surgical treatment of renal cell carcinoma extending into the vena cava.

Fujioka T, Ogiu K, Matsushita Y, Hasegawa M, Sato F, Goto Y, Ishikura K, Tanji S, Aoki H, Okamoto T, et al.

Int J Urol. 1995 Sep;2(4):224-8.

29.

[Clinical study of renal cell carcinoma invading adjacent organs].

Ishikura K, Yoshida N, Hasegawa M, Nomura K, Okamoto T, Tanji S, Fujioka T, Ohhori T, Kubo T.

Hinyokika Kiyo. 1994 May;40(5):373-7. Japanese.

30.

[A case of renal liposarcoma].

Koike H, Ra S, Hasegawa M, Tanji S, Fujioka T, Kubo T.

Hinyokika Kiyo. 1994 Apr;40(4):325-8. Review. Japanese.

31.

[Clinical experience of autologous blood transfusion in patients undergoing nephrectomy with renal cell carcinoma].

Nomura K, Hasegawa M, Ishikura K, Mathuzaka J, Suzuki Y, Yeh KH, Okamoto T, Tanji S, Suzuki K, Fujioka T, et al.

Hinyokika Kiyo. 1992 Feb;38(2):137-41. Japanese.

32.

[Epidermal growth factor in the urine of patients with renal cell carcinoma and bladder tumor].

Ishikura K, Hasegawa M, Nomura K, Okamoto T, Tanji S, Abe T, Fujioka T, Ohhori T, Kubo T.

Hinyokika Kiyo. 1991 Oct;37(10):1229-34. Japanese.

34.

[Studies on metabolism and disposition of sizofiran (SPG), an anti-tumor polysaccharide. III. Degradation and excretion of SPG in rats].

Tanji S, Akima K, Horiba M, Amemiya K, Aimoto T.

Yakugaku Zasshi. 1990 Nov;110(11):869-75. Japanese.

PMID:
2127945
35.

[Antitumor activity of UFT against murine renal cell carcinoma: a study on the suppression tumor metastases].

Fujioka T, Hasegawa M, Ishikura K, Nomura K, Okamoto T, Tanji S, Koike H, Kubo T.

Gan To Kagaku Ryoho. 1990 Oct;17(10):2031-6. Japanese.

PMID:
2221926
36.

[Serum rifampicin concentrations by means of different assay methods and their critical estimation].

Nakagawa H, Tanji S, Tsuda K, Yamada S, Kishida H.

Kekkaku. 1990 May;65(5):317-32. Japanese.

PMID:
2391795
37.

[Clinical efficacy of recombinant interleukin-2 for renal cell carcinoma and the effect of blood transfusion upon the immune response of these patients].

Fujioka T, Kudo T, Ishikura K, Shiraishi M, Tanji S, Okamoto T, Suzuki K, Koike H, Kumagai K, Ohhori T, et al.

Nihon Hinyokika Gakkai Zasshi. 1990 Feb;81(2):296-303. Japanese.

38.

[Studies on metabolism and disposition of sizofiran (SPG), an anti-tumor polysaccharide. II. Effects on hepatic drug-metabolizing enzyme system in rats].

Tanji S, Akima K, Yoshioka M, Nomura K, Horiba M, Aimoto T.

Yakugaku Zasshi. 1990 Feb;110(2):159-62. Japanese.

PMID:
2141074
39.

Combined effects of intraperitoneal administration of recombinant interleukin-2 and streptococcal preparation OK-432 in murine tumors.

Fujioka T, Ishikura K, Tanji S, Okamoto T, Koike H, Aoki H, Ohhori T, Kubo T.

Int J Immunopharmacol. 1990;12(4):419-26.

PMID:
2391188
40.

Recombinant interleukin-2-induced regression of pulmonary metastasis of renal cell carcinoma.

Fujioka T, Tanji S, Koike H, Kumagai K, Kubo T, Ohhori T, Satoh T, Satodate R.

Urol Int. 1990;45(1):58-62.

PMID:
2305498
41.

[Combined effect of intraperitoneally administered OK-432 and recombinant interleukin (rIL-2) against mouse tumors].

Fujioka T, Shiraishi M, Tanji S, Koike H, Kumagai K, Kubo T, Ohhori T.

Nihon Gan Chiryo Gakkai Shi. 1989 May 20;24(5):948-56. Japanese.

PMID:
2789265
42.

[Two cases of metastatic renal tumor].

Koike H, Okamoto T, Tanji S, Fujioka T, Kubo T, Ohhori T.

Hinyokika Kiyo. 1989 Mar;35(3):475-9. Review. Japanese.

43.

[Local immunotherapy with streptococcal preparation, OK-432 in superficial bladder tumors, and common antigens between OK-432 and the tumor].

Fujioka T, Shiraishi M, Tanji S, Koike H, Suzuki K, Kumagai K, Aoki H, Sakuma Y, Ohhori T, Kubo T, et al.

Hinyokika Kiyo. 1989 Feb;35(2):253-7. Japanese.

44.

[The efficacy of recombinant interleukin 2 in local treatment of superficial bladder tumors].

Fujioka T, Shiraishi M, Tanji S, Sato S, Koike H, Aoki H, Suzuki K, Kumagai K, Banya Y, Kubo T, et al.

Hinyokika Kiyo. 1988 Dec;34(12):2115-9. Japanese.

45.

[Cytotoxic activity in mouse tumors by lymphocytes with anti-streptococcal specific antibodies].

Fujioka T, Tanji S, Koike H, Kumagai K, Aoki H, Kubo T, Ohhori T.

Nihon Gan Chiryo Gakkai Shi. 1988 Jun 20;23(6):1243-7. Japanese. No abstract available.

PMID:
3068321
46.

[Changes in ASP (antigroup-A streptococcal C polysaccharide antibody) and cardiac and renal effects in cases of urogenital cancers during OK-432 immunotherapy, streptococcus preparation].

Tanji S, Koike H, Kumagai K, Fujioka T, Kubo T, Ohhori T, Yoshida I.

Nihon Hinyokika Gakkai Zasshi. 1988 Jan;79(1):49-57. Japanese. No abstract available.

PMID:
3398379
47.

[Rhabdomyosarcoma of the prostate: report of a case and review of the literature].

Seino K, Tanji S, Yamamoto T, Fujizuka I, Ohinata M, Kubo T, Ohhori T.

Hinyokika Kiyo. 1987 Nov;33(11):1906-12. Review. Japanese.

48.

[Effect of selective intra-arterial infusion of OK-432 against renal cell cancers].

Fujioka T, Tanji S, Koike H, Kumagai K, Suzuki K, Aoki H, Banya Y, Kubo T, Ohhori T.

Hinyokika Kiyo. 1987 Jun;33(6):832-7. Japanese.

49.
50.

[A case of bilateral testicular tumor of germ cell origin].

Kawamura S, Takata K, Yoshida I, Tanji S.

Hinyokika Kiyo. 1986 Jun;32(6):881-7. Japanese.

Supplemental Content

Support Center